Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT03888612 · COMPLETED

Trial details

NCT number: NCT03888612
Sponsor: Arvinas Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2019-03-01
Primary completion: 2024-04-29
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.